The costs for drug discovery and development are skyrocketing, but AI (artificial intelligence) is introducing new efficiencies to help find effective treatments faster.
A study in 2020 concluded that the estimated median capitalized research and development cost per product was $985 million. Contributing factors to this included larger trial sizes, the need to assess health technology, the requirement to provide data on comparative drugs’ effectiveness, and most
Read More
Clinical Trials | News, Analysis, Insights - HIT Consultant
ObvioHealth & Oracle Collaborate to Seamlessly Integrate Diverse Data Sets Into Decentralized Clinical Trials in APAC
What You Should Know:
- Today, ObvioHealth and Oracle have announced a partnership to enable the rapid collection, integration and analysis of this complex data to get breakthrough therapies to market faster and cheaper within the APAC region. This partnership will integrate ObvioGo, ObvioHealth’s next generation decentralized clinical trial (DCT) platform and mobile app, and Oracle Clinical One Cloud Service, facilitating pharma-grade analytics and reporting that can
Read More
SURGE Therapeutics Raises $26M to Accelerate Intraoperative Immunotherapy
What You Should Know:
- SURGE Therapeutics (SURGE) recently announced the completion of a $26 million Series A financing led by Camford Capital, with participation from Khosla Ventures, Intuitive Ventures, Pitango HealthTech, 8VC, Alumni Ventures, and the Cancer Research Institute.
- The funds will be used to accelerate the development of the SURGE™ intraoperative immunotherapy approach, expand the team, and initiate clinical trials for its injectable biodegradable hydrogel.
Using
Read More
Eclipse and Mayo Clinic Create Nucleus RadioPharma for Cancer Patients
What You Should Know:
- Eclipse, a venture capital firm investing in the digital transformation of the world's physical industries, and Mayo Clinic, a leading nonprofit health organization, recently announced the creation and seed funding of Nucleus RadioPharma, a new company built to ensure cancer patients can access potentially life-saving radiopharmaceuticals by developing technologies to modernize the clinical development, manufacturing, and supply chain of these promising new
Read More
Accommodations Increase Clinical Trial Participation for Patients of Color, Survey Reveals
What You Should Know:
- In a recent patient-centric survey, SubjectWell found that accommodations for all patients, including free treatment and study compensation, increase interest in clinical trial participation – particularly for patients of color.
- However, overall, using value-based messaging, adding education to the recruiting process and reducing friction to participation – are universally impactful, not just for diverse populations, and that certain barriers
Read More
Qnovia Secures $17M to Advance Inhalable Therapeutics Pipeline
What You Should Know:
- Qnovia (formerly Respira Technologies)—a pharma company developing inhaled therapeutics with an initial focus on nicotine replacement therapy (NRT) and cardiopulmonary diseases—has raised $17M in Series A funding led by Blue Ledge Capital and included DG Ventures, Evolution VC Partners, Gaingels, TL Capital, and Vice Ventures.
- Qnovia will use the Series A proceeds to advance its NRT drug candidate through an IND submission with the FDA and begin human
Read More
XpertDox Secures $1.5M to Automate Medical Coding Process
What You Should Know:
- Today, XpertDox, LLC., a Birmingham, AL-based revenue cycle company specializing in autonomous medical coding powered by artificial intelligence raises $1.5M from TN3, LLC, an Arizona based Private Equity Capital firm.
- XpertDox's XpertCoding solution harnesses the power of artificial intelligence in order to autonomously code medical claims faster, more accurately, and cheaper than traditional manual processes. XpertDox is utilizing the funding to
Read More
Virtual Reality Therapy May Serve as Effective Adjunct To Anesthesia For Surgical Procedures
What You Should Know:
- The results of a clinical trial using software from XRHealth, developer and operator of virtual treatment rooms in the metaverse, published in PLOS ONE demonstrated that virtual reality therapy may serve as an effective adjunct to anesthesia for surgical procedures. The trials were conducted with XRHealth’s immersive virtual reality software.
- The results of the trial showed that the majority of patients (13/17) using the XRHealth VR technology did not need
Read More
Children’s Oncology Group Taps Tempus to Provide Genomic Sequencing for Pediatric Cancer Patients
What You Should Know:
-Tempus, an $8B precision medicine company, is providing genomic sequencing for 300 eligible pediatric cancer patients annually through their new collaboration with the Children’s Oncology Group (COG). Tempus’ support for COG – a leader in pediatric oncology research – will assist with matching patients to clinical trials like the Pediatric MATCH Screening Trial APEC1621SC (NCT03155620), which is studying the effectiveness of genetic testing-directed treatment in
Read More
Epic Launches Life Sciences Program with Clinical Trial Matchmaking
What You Should Know:
- Epic launches Life Sciences program, expanding its work to bring together the disconnected parts of healthcare.
- The Epic Life Sciences program is built to help providers, pharmaceutical companies, and medical device manufacturers recruit research participants, expand clinical trial access to underrepresented communities, and speed up the development of new therapies.
Unifying Clinical Research with Care Delivery
Providers across the world use Epic to
Read More
